Liver histology of an afibrinogenemic patient with the B
-L353R mutation showing no evidence of hepatic endoplasmic reticulum storage disease (ERSD); comparative study in COS-1 cells of the intracellular processing of the B
-L353R fibrinogen vs. the ERSD-associated
-G284R mutant
Authors: DUGA, S.1; BRAIDOTTI, P.2; ASSELTA, R.1; MAGGIONI, M.2; SANTAGOSTINO, E.3; PELLEGRINI, C.2; COGGI, G.2; MALCOVATI, M.1; TENCHINI, M. L.1
Source: Journal of Thrombosis and Haemostasis, Volume 3, Number 4, April 2005 , pp. 724-732(9)
Publisher: Wiley-Blackwell
Abstract:
Summary. Background: Type I fibrinogen deficiencies (hypofibrinogenemia and afibrinogenemia) are rare congenital disorders characterized by low or unmeasurable plasma fibrinogen antigen levels. Their genetic bases are represented by mutations within the three fibrinogen genes. Among the 11 reported missense mutations, a few have been characterized by expression studies and found to have an impaired fibrinogen assembly and/or secretion. Histopathological analyses were previously reported in two hypofibrinogenemic cases with discernible hepatic disease, revealing that both underlying mutations (
-Gly284Arg and
-Arg375Trp) were associated with hepatic fibrinogen endoplasmic reticulum storage disease (ERSD). Objective: The objective of this study was to investigate the liver histology in an afibrinogenemic patient, homozygous for the B
-Leu353Arg mutation, and to study the intracellular processing of the mutant protein. Patients and methods: Liver histology was evaluated by light microscopy, electron microscopy and immunocytochemistry. Intracellular processing of mutant fibrinogen was analyzed by pulsechase labeling and immunoprecipitation experiments. Messenger RNA levels were determined by real-time reverse transcriptionpolymerase chain reaction (RT-PCR). Results: The histopathological characterization of the liver showed no signs of fibrinogen accumulation, a difference from the previously reported findings in two hypofibrinogenemic kindreds with ERSD. To evaluate whether the B
-Leu353Arg mutation and the ERSD-associated
-Gly284Arg mutation affected intracellular fibrinogen trafficking differently, both mutant proteins were expressed in COS-1 cells. B
-Leu353Arg led to a more severe secretion defect, but no differences that could explain phenotypegenotype correlation were found in the intracellular processing. Endoglycosidase-H analysis demonstrated a secretion block before translocation to the Golgi medial stacks. Real-time RT-PCR studies showed normal levels of the B
mRNA in the patient's liver. Conclusions: The results confirm that B
-Leu353Arg is associated with impaired fibrinogen secretion, but not with hepatic ERSD.
Keywords: congenital afibrinogenemia; endoplasmic reticulum storage disease; liver histopathology
Document Type: Research article
DOI: http://dx.doi.org/10.1111/j.1538-7836.2005.01229.x
Affiliations: 1: Department of Biology and Genetics for Medical Sciences, University of Milan, Milan, Italy 2: Department of Medicine, Surgery and Dentistry A.O. San Paolo and IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico) Maggiore Hospital, University of Milan, Milan, Italy 3: Angelo Bianchi Bonomi Hemophilia and Thrombosis Center and Fondazione Luigi Villa, Department of Internal Medicine, University of Milan and IRCCS Maggiore Hospital, Milan, Italy
Publication date: 2005-04-01
- In this: publication
- By this: publisher
- In this Subject: Allergy & Immunology
- By this author: DUGA, S. ; BRAIDOTTI, P. ; ASSELTA, R. ; MAGGIONI, M. ; SANTAGOSTINO, E. ; PELLEGRINI, C. ; COGGI, G. ; MALCOVATI, M. ; TENCHINI, M. L.

Shopping cart
Receive new issue alert
Get Permissions